DrugPatentWatch Database Preview
BETA-VAL Drug Profile
see a sample report or, see our see our flat-rate plans
When do Beta-val patents expire, and what generic alternatives are available?
The generic ingredient in BETA-VAL is betamethasone valerate. There are sixty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for BETA-VAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 37 |
| Patent Applications: | 3,211 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BETA-VAL at DailyMed |
Pharmacology for BETA-VAL
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for BETA-VAL
Synonyms for BETA-VAL
| (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate |
| (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate |
| (1R,2S,10S,11S,13S,14R,15S,17S)-1-FLUORO-17-HYDROXY-14-(2-HYDROXYACETYL)-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PENTANOATE |
| (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate |
| (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p |
| [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate |
| 1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate |
| 12772-60-0 |
| 149665-14-5 |
| 152M445 |
| 2152-44-5 |
| 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate |
| 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate |
| 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate # |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate |
| 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate |
| 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate |
| 944728-94-3 |
| 9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate |
| 9alpha-Fluoro-16beta-methylprednisolone 17-valerate |
| 9IFA5XM7R2 |
| AB01274710_02 |
| AB01274710-01 |
| AB2000222 |
| AC1L285F |
| AKOS015994704 |
| AN-14218 |
| Bedermin |
| beta-Methasone 17-valerate |
| Beta-Val (TN) |
| Betaderm |
| Betamethason-17-valerate |
| Betamethasone 17-valerate |
| Betamethasone 17a-valerate |
| Betamethasone 17alpha-valerate |
| BETAMETHASONE VALERATE |
| Betamethasone Valerate (Betamethasone 17-Valerate) |
| Betamethasone valerate (Betnovate) |
| Betamethasone valerate (JP17/USP) |
| Betamethasone valerate [USAN:BAN:JAN] |
| Betamethasone valerate [USAN:USP:JAN] |
| Betamethasone-17-valerate |
| Betatrex |
| Betatrex (Salt/Mix) |
| Betaval |
| Betnesol V |
| Betnesol-V |
| Betneval |
| Betnovate |
| Betnovate;Celestone;Betaderm;Luxiq |
| Betnovateat |
| Betoid |
| Bettamousse |
| Bextasol |
| C27H37FO6 |
| CAS-2152-44-5 |
| Celestan V |
| Celestan-V |
| Celestane V |
| Celestoderm |
| Celestoderm-V |
| Celeston valerate |
| CHEBI:31277 |
| CHEMBL1497 |
| Chlorophytum Borivilanum |
| D01357 |
| D03SXE |
| Dermosol |
| Dermovaleas |
| DR002949 |
| DSSTox_CID_2673 |
| DSSTox_GSID_22673 |
| DSSTox_RID_76684 |
| DTXSID7022673 |
| Ecoval 70 |
| EINECS 218-439-3 |
| entanoate |
| Flubenisolonvalerate |
| Fuciderm |
| Gentocin (Salt/Mix) |
| Gentocin (Veterinary) |
| KS-1198 |
| LS-118456 |
| Luxiq |
| Luxiq (TN) |
| MFCD00867446 |
| MolPort-003-933-651 |
| NCGC00255185-01 |
| NCGC00274064-01 |
| PL043955 |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)- |
| Rinderon V |
| Rinderon-V (TN) |
| RL02645 |
| s1690 |
| SCHEMBL7270 |
| SNHRLVCMMWUAJD-SUYDQAKGSA-N |
| ST075178 |
| Stanoval |
| Tokuderm |
| Topagen (Salt/Mix) |
| Topagen (Veterinary) |
| Tox21_302288 |
| UNII-9IFA5XM7R2 |
| Valnac |
| ZINC3882052 |
US Patents and Regulatory Information for BETA-VAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G And W Labs Inc | BETA-VAL | betamethasone valerate | CREAM;TOPICAL | 018642-001 | Mar 24, 1983 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| G And W Labs Inc | BETA-VAL | betamethasone valerate | LOTION;TOPICAL | 070072-001 | Jun 27, 1985 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| G And W Labs Inc | BETA-VAL | betamethasone valerate | OINTMENT;TOPICAL | 070069-001 | Dec 19, 1985 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
